NEXIMMUNE (NEXI) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 7 53 sessions, August 8, 2025 to September 8, 2026
- Largest daily move
- +4900% close of September 12, 2025
- 1-year change
- -50% closing prices, August 8, 2025 to September 8, 2026
Company Description
NEXIMMUNE (OTC: NEXI) is classified in the biotechnology industry within the Healthcare sector.
NEXI has declined 50.0% over the past year. The last closing price was $0.0001.
For FY2023, NEXIMMUNE reported net income of -$32.3M and diluted earnings per share of -$30.82.
This page collects what Stock Titan holds for NEXI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NEXIMMUNE (NEXI) closed at $0.0001 on September 8, 2026. Over the past 12 months, the price has lost 50.0%.
NEXI Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NEXIMMUNE has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include offering, partnership, stock split, earnings, clinical trial. View all NEXI news →
SEC Filings
Financial Highlights
operating income reached -$33.0M, and net income was -$32.3M. Diluted earnings per share stood at -$30.82. The company generated -$31.4M in operating cash flow. With a current ratio of 1.06, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in NEXIMMUNE (NEXI) currently stands at 112 shares, representing 0.0% of the float. Since September 2025, short interest has decreased by 96.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for NEXIMMUNE (NEXI) currently stands at 1.6 days, down 33% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 92.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 20.7 days.
NEXI Company Profile & Sector Positioning
NEXIMMUNE (NEXI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NEXI often look at related companies in the same sector, including REGENERX BIOPHARMS INC (RGRX), Eloxx Pharmaceuticals, Inc. (ELOX), GRITSTONE BIO INC (GRTSQ), EFFECTOR THERAPUTCS INC (EFTR), and INNOVEREN SCIENTIFIC INC (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NEXI's relative position within its industry.